Advantages and limitations of radioactive stents.
The concept of radioactive stents was initiated to prevent restenosis after angioplasty in patients with coronary artery disease. We review the modes of fabrication, dosimetry and the biological effects of radioactive stents. Radioactive stents deliver ionizing radiation continuously at very low-dose rates according to the half-life of the incorporated radioisotopes. The activity levels of radioactive stents are up to 10,000 times lower than activity levels of sources used for catheter-based vascular brachytherapy. Radioactive stents allow uniform dose distribution and precise dosimetry because of the direct source contact with the circumference of the vessel. Animal studies show that these stents can potently inhibit smooth muscle cell proliferation and neointimal hyperplasia. A persistent inhibition of neointimal hyperplasia appears to be dose dependent. Local or systemic side effects related to the irradiation were not observed. A limitation of radioactive stents could be the dose-dependent delay in stent endothelialization which, however, did not cause thrombotic vessel occlusion in animal experiments. Whether a delay in stent endothelialization is associated with an increased rate of occlusive stent thrombosis in humans requires further studies.
Hehrlein
C
C
Department of Cardiology, University of Heidelberg, Germany.
Kübler
W
W
D000818:Animals; D001918:Brachytherapy / Q000295:instrumentation* / Q000379:methods; D003037:Cobalt Radioisotopes / Q000008:administration & dosage; D003327:Coronary Disease / Q000517:prevention & control* / Q000532:radiotherapy / Q000628:therapy; D003331:Coronary Vessels / Q000528:radiation effects*; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D012008:Recurrence; D015607:Stents
D003037:Cobalt Radioisotopes; D010761:Phosphorus Radioisotopes